In the latest trading session, 6.74 million Silexion Therapeutics Corp (NASDAQ:SLXN) shares changed hands as the company’s beta touched 0.02. With the company’s most recent per share price at $1.85 changed hands at -$0.09 or -4.64% at last look, the market valuation stands at $2.97M. SLXN’s current price is a discount, trading about -6495.68% off its 52-week high of $122.02. The share price had its 52-week low at $1.80, which suggests the last value was 2.7% up since then. When we look at Silexion Therapeutics Corp’s average trading volume, we note the 10-day average is 0.13 million shares, with the 3-month average coming to 797.77K.
Silexion Therapeutics Corp (NASDAQ:SLXN) trade information
Instantly SLXN was in red as seen in intraday trades today. With action -13.95%, the performance over the past five days has been red. The company’s shares are showing year-to-date downside of -7.96%, with the 5-day performance at -13.95% in the red. However, in the 30-day time frame, Silexion Therapeutics Corp (NASDAQ:SLXN) is -31.99% down. Looking at the short shares, we see there were 35842.0 shares sold at short interest cover period of 0.23 days.
SLXN Dividends
Silexion Therapeutics Corp is expected to release its next quarterly earnings report in February.
Silexion Therapeutics Corp (NASDAQ:SLXN)’s Major holders
With 587.0 shares estimated at $1041.0 under it, the former controlled 0.00% of total outstanding shares.
